Home FDA labels b1a5b968-4f80-4329-8e35-94ad7d7aa04e DERCUT openFDA label record# This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
Brand name DERCUT
Generic name EUPHORBIA RESINIFERA RESIN, GOLDENSEAL, WOOD CREOSOTE, TOXICODENDRON PUBESCENS SHOOT, SEMPERVIVUM TECTORUM LEAF, BELLIS PERENNIS, VINCA MINOR, AND VIOLA TRICOLOR
Manufacturer PEKANA Naturheilmittel GmbH
Product type HUMAN OTC DRUG
SPL set ID 502d5e60-ea81-4fd6-8d51-3e263b5456a3
SPL ID b1a5b968-4f80-4329-8e35-94ad7d7aa04e
Version 3
Effective date 2022-01-14
Source export date 2026-10-12
Source partition 7
Source file https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key raw/openfda/drug-label/2026-10-12/ff22b88bd32e56cbc369af80345075227138a42b1b3ba9a84f038fd5493a7a47/drug-label-0007-of-0014.json.zip
Source manifest SHA-256 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run 20261013T011858Z
Imported at 2026-10-13 02:02:10 Harmonized routes table Harmonized routes CUTANEOUS
Harmonized identifier links# Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 18 matching rows.
Warnings cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Warnings sections page 1 of 1 · 1 matching rows.
warnings Warnings For external use only. Do not use on open wounds! If symptoms persist, contact a licensed practitioner. If you have known sensitivity to any of the ingredients, please consult your licensed practitioner before use. If you are pregnant or nursing a baby, seek the advice of a health care professional before use. Keep out of the reach of children.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.